ViCentra Closes EUR 65M (USD 74M) Series C Funding
Proceeds will be used for commercial European launch of updated Kaleido insulin patch pump system including automated insulin delivery (AID) or closed loop
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Proceeds will be used for commercial European launch of updated Kaleido insulin patch pump system including automated insulin delivery (AID) or closed loop
“This transformational funding is a testament to the potential the Novasight Hybrid System has on a global scale. It provides the Company with the runway to reach important operational and commercial milestones as we drive the value proposition of this innovative system,” said Thomas Looby, chief executive officer, Conavi Medical.
Financing enables the company to execute and accelerate growth plans as well as further develop the company’s innovation pipeline to deliver superior navigation technology to physicians and patients worldwide.